share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

辉瑞 | 4:持股变动声明-高管 BOURLA ALBERT
美股SEC公告 ·  08/16 15:23

Moomoo AI 已提取核心信息

Pfizer Inc. (PFE) Chairman & CEO, Albert Bourla, has been reported to engage in a transaction involving the company's stock. The action, which took place on August 15, 2024, is part of the regular financial disclosures made by corporate executives. However, the details regarding the number of shares involved, the nature of the transaction, and the total value remain undisclosed. Investors are advised to monitor official filings for complete transaction details.
Pfizer Inc. (PFE) Chairman & CEO, Albert Bourla, has been reported to engage in a transaction involving the company's stock. The action, which took place on August 15, 2024, is part of the regular financial disclosures made by corporate executives. However, the details regarding the number of shares involved, the nature of the transaction, and the total value remain undisclosed. Investors are advised to monitor official filings for complete transaction details.
辉瑞制药公司(PFE)董事长兼CEO阿尔伯特·布拉被报道参与了公司股票的交易。这一行动发生在2024年8月15日,是公司高管定期进行的财务披露的一部分。但是,有关涉及的股票数量、交易性质和总价值的细节仍未公开。投资者应监督官方文件以了解完整的交易细节。
辉瑞制药公司(PFE)董事长兼CEO阿尔伯特·布拉被报道参与了公司股票的交易。这一行动发生在2024年8月15日,是公司高管定期进行的财务披露的一部分。但是,有关涉及的股票数量、交易性质和总价值的细节仍未公开。投资者应监督官方文件以了解完整的交易细节。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息